Sage Therapeutics - The FDA has granted Fast Track Designation to SAGE-718.katrina4384Feb 26, 20220 min readUpdated: Mar 31, 2022
uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec(AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression
Comments